Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Anti‐TB therapy vs placebo

Adverse events · maintenance of remission in Crohn's disease

It is very uncertain whether anti‐TB therapy changes adverse events compared with placebo (very low certainty).

1 finding from 1 review

Anti‐tuberculous therapy for maintenance of remission in Crohn's disease 2016 · Cochrane Headline outcomes only
RR 2.57 [1.45, 4.55]
4 studies · 322 participants
Very low

Anti‐TB therapy vs placebo

Withdrawals due to adverse events · maintenance of remission in Crohn's disease

It is very uncertain whether anti‐TB therapy changes withdrawals due to adverse events compared with placebo (very low certainty).

1 finding from 1 review

Anti‐tuberculous therapy for maintenance of remission in Crohn's disease 2016 · Cochrane Headline outcomes only
RR 1.29 [0.6, 2.77]
4 studies · 322 participants
Very low

Intermittent short‐course anti‐TB regimens vs daily anti‐TB regimens

Treatment‐limiting adverse events · Children with TB1

It is very uncertain whether intermittent short‐course anti‐TB regimens changes treatment‐limiting adverse events compared with daily anti‐TB regimens (very low certainty).

1 finding from 1 review

Intermittent versus daily therapy for treating tuberculosis in children 2014 · Cochrane Headline outcomes only
RR 0.4 [0.06, 2.6]
4 studies · 441 participants
Very low